Delayed response of insulin-stimulated fluorine-18 deoxyglucose uptake in glucose transporter-4-null mice hearts

Journal of the American College of Cardiology

Volumn 43, Issue 9, 2004, Pages 1690-1697

  Simões, Marcus V ^a   Egert, Silvia ^a   Ziegler, Sibylle ^a   Miyagawa, Masao ^a   Reder, Sybille ^a   Lehner, Terry ^a   Nguyen, Ngoc ^a   Charron, Maureen J ^b   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

2 deoxyglycose; 2 DG; 18F 2 deoxy 2 fluoro D glucose; FDG; G4N; glucose transporter; GLUT; GLUT4 null mice; MGU; myocardial glucose uptake; PET; positron emission tomography; standard uptake value; SUV; wild type mice; WT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART FUNCTION; HEART PERFUSION; HEART WEIGHT; IMAGE ANALYSIS; ISOLATED HEART; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORTER TYPE 4; HEART RATE; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; MODELS, CARDIOVASCULAR; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MYOCARDIUM; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 18344412288     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.12.038     Document Type: Article

References (40)

1. Depre C., Vanoverschelde J.L.J., Taegtmeyer H. Glucose for the heart. Circulation. 99:1999;578-588
2. Depre C., Rider M.H., Hue L. Mechanisms of control of heart glycolysis. Eur J Biochem. 258:1998;277-290
3. Schönekess B.O., Allard M.F., Lopashuk G.D. Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ Res. 77:1995;726-734
4. Friehs I., Moran A.M., Stamm C., et al. Impaired glucose transporter activity in pressure-overload hypertrophy is an early indicator of progression to failure. Circulation. 100:(Suppl II):1999;II187-II193
5. Kudej R.K., White L.T., Kudej A.B., et al. Brief increase in carbohydrate oxidation after reperfusion reverses myocardial stunning in conscious pigs. Circulation. 106:2002;2836-2841
6. Vanoverschelde J.J., Janier M.F., Bakke J.E., Marshall D.R., Bergmann S.R. Rate of glycolysis during ischemia determines extent of ischemic injury and function recovery after reperfusion. Am J Physiol. 267:1994;H1785-H1794
7. Opie L.H., Sack M.N. Metabolic plasticity and the promotion of cardiac protection in ischemia and ischemic preconditioning. J Mol Cell Cardiol. 34:2002;1077-1089
8. Apstein C.S. Glucose-insulin-potassium for acute myocardial infarction Remarkable results from a new prospective, randomized trial. Circulation. 98:1998;2223-2226
9. Taegtmaeyer H. Switching metabolic genes to build a better heart. Circulation. 106:2002;2043-2045
10. Manchester J., Kong X., Nerbonne J., et al. Glucose transport and phosphorylation in single cardiac myocytes Rate-limiting steps in glucose metabolism. Am J Physiol. 266:1994;E326-E333
11. King L.M., Opie L.H. Glucose delivery is a major determinant of glucose utilization in the ischemic myocardium with a residual coronary flow. Cardiovasc Res. 39:1998;381-392
12. Mueckler M. Family of glucose transporter genes Implication for glucose homeostasis and diabetes. Diabetes. 39:1990;6-11
13. Slot J.W., Geuze H.J., Gigengack S., James D.E., Lienhard G.E. Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci USA. 88:1991;7815-7819
14. Egert S., Nguyen N., Schwaiger M. Contribution of α-adrenergic and β-adrenergic stimulation to ischemia-induced glucose transporter GLUT4 and GLUT1 translocation in the isolated perfused rat heart. Circ Res. 84:1999;1407-1415
15. Sun D., Nguyen N., Degrado T.R., Schwaiger M., Brosius F.C. 3rd. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation. 89:1994;793-798
16. Fischer Y., Thomas J., Sevilla L., et al. Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. J Biol Chem. 272:1997;7085-7092
17. Young L.H., Renfu Y., Russell R., et al. Low-flow ischemia leads to translocation of canine heart GLUT4 and GLUT1 glucose transporters to the sarcolemma in vivo. Circulation. 95:1997;415-422
18. Paternostro G., Pagano D., Gnecchi-Ruscone T., Bonser R.S., Camici P.G. Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res. 42:1999;246-253
19. Razeghi P., Young M.E., Cockrill T.C., Frazier O.H., Taegtmeyer H. Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure. Circulation. 106:2002;407-411
20. Kainulainen H., Breiner M., Schurmann A., Marttinem A., Virjo A., Joost H.G. In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT4 in heart and various types of skeletal muscle from streptozotocin-diabetic rats. Biochim Biphys Acta. 1225:1994;275-282
21. Liao R., Jain M., Cui L., et al. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation. 106:2002;2125-2131
22. Katz E.B., Stenbit A.E., Hatton K., DePinho R., Charron M.J. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature. 377:1995;151-155
23. Weiss R.G., Chathan J.C., Georgakopolous G., et al. Effect of GLUT4 ablation on in vivo cardiac energetics and function in adult senescent mice. FASEB J. 16:2002;613-615
24. Stenbit A.E., Katz E.B., Chatham J.C., et al. Preservation of glucose metabolism in hypertrophic GLUT4-null hearts. Am J Physiol. 279:2000;H313-H318
25. Ryder J.W., Kawano Y., Chibalin A.V., et al. In vitro analysis of the glucose transport system in GLUT4-null skeletal muscle. Biochem J. 342:1999;321-328
26. Tada H., Thompson C.I., Recchia F.A., et al. Myocardial glucose uptake is regulated by nitric oxide via endothelial nitric oxide synthase in Langendorff mouse heart. Circ Res. 86:2000;270-274
27. Tian R., Abel D. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation. 103:2001;2961-2966
28. Abel E.D., Kaulbach H.C., Tian R., et al. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest. 104:1999;1703-1714
29. Joost H.G., Bell G.I., Best J.D., et al. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab. 282:2002;E974-E976
30. Laybutt D.R., Thompson A.L., Cooney G.J., Kraegen E.W. Selective chronic regulation of GLUT1 and GLUT4 content by insulin, glucose, and lipid in rat cardiac muscle in vivo. Am J Physiol. 273:1997;H1309-H1316
31. Pryor P.R., Liu S.C., Clark A.E., Yang J., Holman G.D., Tosh D. Chronic insulin effects on insulin signaling and GLUT4 endocytosis are reversed by metformin. Biochem J. 348:2000;83-91
32. Kozka I.J., Clark A.E., Holman G.D. Chronic treatment with insulin selectively down-regulates cell-surface GLUT4 glucose transporters in 3T3-L1 adipocytes. J Biol Chem. 266:1991;11726-11731
33. Paternostro G., Camici P.G., Lammerstma A.A., et al. Cardiac and skeletal muscle insulin resistance in patients with coronary artery disease A study with positron emission tomography. J Clin Invest. 98:1996;2094-2099
34. Paternostro G., Clarke K., Heath J., Seymour A.M., Radda G.K. Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc Res. 30:1995;205-211
35. Friehs I., Moran A.M., Stamm C., et al. Impaired glucose transporter activity in pressure-overload hypertrophy is an early indicator of progression to failure. Circulation. 100:(Suppl II):1999;II187-II193
36. Kofoed K.F., Carstensen S., Hove J.D., et al. Low whole-body insulin sensitivity in patients with ischemic heart disease is associated with impaired myocardial glucose uptake predictive of poor outcome after revascularization. Eur J Nucl Med. 29:2002;991-998
37. Schelbert H.R., Phelps M.E., Hoffman E., Huang S.C., Kuhl D.E. Regional myocardial blood flow, metabolism, and function assessed noninvasively with positron emission tomography. Am J Cardiol. 46:1980;1269-1277
38. Hariharan R., Bray M., Ganim R., Doenst T., Goodwin G.W., Taegtmeyer H. Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing glucose uptake. Circulation. 91:1995;2299-2301
39. Mochizuki T., Eberli F.R., Ngoy S., et al. Effects of brief repetitive ischemia on contractility, relaxation, and coronary flow Exaggerated postischemic diastolic dysfunction in pressure-overload hypertrophy. Circ Res. 73:1993;550-558
40. Abbud Z.A., Shindler D.M., Wilson A.C., et al. the Myocardial Infarction Data Acquisition System Study Group. Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction A statewide study. Am Heart J. 130:1995;51-58